tiprankstipranks
Trending News
More News >
Island Pharmaceuticals Ltd (AU:ILA)
ASX:ILA
Australian Market
Advertisement

Island Pharmaceuticals Ltd (ILA) Price & Analysis

Compare
16 Followers

ILA Stock Chart & Stats


Financials

Options Prices

Currently, No data available
---

Ownership Overview

3.55%96.45%
Mutual Funds
― Other Institutional Investors
96.45% Public Companies and
Individual Investors

ILA FAQ

What was Island Pharmaceuticals Ltd’s price range in the past 12 months?
Island Pharmaceuticals Ltd lowest share price was AU$0.06 and its highest was AU$0.28 in the past 12 months.
    What is Island Pharmaceuticals Ltd’s market cap?
    Island Pharmaceuticals Ltd’s market cap is AU$37.09M.
      When is Island Pharmaceuticals Ltd’s upcoming earnings report date?
      Island Pharmaceuticals Ltd’s upcoming earnings report date is Aug 21, 2025 which is in 23 days.
        How were Island Pharmaceuticals Ltd’s earnings last quarter?
        Island Pharmaceuticals Ltd released its earnings results on Feb 27, 2025. The company reported -AU$0.011 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.011.
          Is Island Pharmaceuticals Ltd overvalued?
          According to Wall Street analysts Island Pharmaceuticals Ltd’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Island Pharmaceuticals Ltd pay dividends?
            Island Pharmaceuticals Ltd does not currently pay dividends.
            What is Island Pharmaceuticals Ltd’s EPS estimate?
            Island Pharmaceuticals Ltd’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Island Pharmaceuticals Ltd have?
            Island Pharmaceuticals Ltd has 247,235,090 shares outstanding.
              What happened to Island Pharmaceuticals Ltd’s price movement after its last earnings report?
              Island Pharmaceuticals Ltd reported an EPS of -AU$0.011 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 14.286%.
                Which hedge fund is a major shareholder of Island Pharmaceuticals Ltd?
                Currently, no hedge funds are holding shares in AU:ILA

                Company Description

                Island Pharmaceuticals Ltd

                Island Pharmaceuticals Ltd (ILA) is a biopharmaceutical company focused on developing and commercializing innovative therapies for the prevention and treatment of mosquito-borne viral diseases. The company's primary focus is on its lead product, ISLA-101, a drug aimed at preventing and treating dengue fever and other flavivirus infections. Island Pharmaceuticals leverages its expertise in viral disease research and drug development to address significant unmet medical needs in global health.
                Similar Stocks
                Company
                Price & Change
                Follow
                Actinogen Medical
                Biotron
                Immutep Ltd
                Recce Pharmaceuticals Ltd.
                Arovella Therapeutics Limited
                Popular Stocks
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis